Novel prostate brachytherapy technique: Improved dosimetric and clinical outcome

Radiotherapy and Oncology

Volumn 88, Issue 1, 2008, Pages 121-126

  Nobes, Jenny P ^a   Khaksar, Sara J ^a   Hawkins, Maria A ^a   Cunningham, Melanie J ^a   Langley, Stephen E M ^a   Laing, Robert W ^a  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Erectile dysfunction; Implant technique; Penile bulb; Prostate brachytherapy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PENIS; PRIORITY JOURNAL; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

BRACHYTHERAPY; ERECTILE DYSFUNCTION; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PENIS; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 45849098368     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.04.012     Document Type: Article

References (44)

1. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy 〈72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
2. Khaksar S.J., Laing R.W., Henderson A., et al. Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy. BJU Int 98 (2006) 1210-1215
3. Khaksar S.J., Langley S.E., Lovell D., et al. Interstitial low dose rate brachytherapy for prostate cancer - a focus on intermediate- and high-risk disease. Clin Oncol (R Coll Radiol) 18 (2006) 513-518
4. Penson D.F., Feng Z., Kuniyuki A., et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21 (2003) 1147-1154
5. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 283 (2000) 354-360
6. Valicenti R.K., Bissonette E.A., Chen C., et al. Longitudinal comparison of sexual function after 3-dimensional conformal radiation therapy or prostate brachytherapy. J Urol 168 (2002) 2499-2504 [discussion 2504]
7. Henderson A., Laing R.W., and Langley S.E. Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A review. Eur Urol 45 (2004) 134-141
8. Crawford E.D., Bennett C.L., Stone N.N., et al. Comparison of perspectives on prostate cancer: analyses of survey data. Urology 50 (1997) 366-372
9. NIH Consensus Conference. Impotence. NIH consensus development panel on impotence. JAMA 1993;270:83-90.
10. Chaikin D.C., Broderick G.A., Malloy T.R., et al. Erectile dysfunction following minimally invasive treatments for prostate cancer. Urology 48 (1996) 100-104
11. Incrocci L., Slob A.K., and Levendag P.C. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 52 (2002) 681-693
12. Stock R.G., Kao J., and Stone N.N. Penile erectile function after permanent radioactive seed implantation for treatment of prostate cancer. J Urol 165 (2001) 436-439
13. Merrick G.S., Wallner K., Butler W.M., et al. Short-term sexual function after prostate brachytherapy. Int J Cancer 96 (2001) 313-319
14. Zelefsky M.J., and Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 40 (1998) 129-133
15. Fisch B.M., Pickett B., Weinberg V., et al. Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology 57 (2001) 955-959
16. Merrick G.S., Wallner K., Butler W.M., et al. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 50 (2001) 597-604
17. Merrick G.S., Butler W.M., Wallner K.E., et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 62 (2005) 437-447
18. Merrick G.S., Butler W.M., Dorsey A.T., et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 48 (2000) 1069-1074
19. Lee W.R., deGuzman A.F., Bare R.L., et al. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: evidence for a learning curve in the first year at a single institution. Int J Radiat Oncol Biol Phys 46 (2000) 83-88
20. Battermann J.J., and van Es C.A. The learning curve in prostate seed implantation. Cancer Radiother 4 Suppl. 1 (2000) 119s-122s
21. American Joint Committee on Cancer (AJCC). Available from: http://www.cancer.gov/cancertopics/pdq/treatment/prostate/HealthProfessional/page3.
22. Merrick G.S., Butler W.M., Galbreath R.W., et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 52 (2002) 893-902
23. Merrick G.S., Butler W.M., Wallner K.E., et al. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction. Int J Radiat Oncol Biol Phys 54 (2002) 1055-1062
24. Merrick G.S., and Butler W.M. Modified uniform seed loading for prostate brachytherapy: rationale, design, and evaluation. Tech Urol 6 (2000) 78-84
25. Steggerda M.J., Moonen L.M., van der Poel H.G., et al. The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate. Radiother Oncol 83 (2007) 11-17
26. Nobes J.P., Laing R., and Langley S. The value of Day 1 imaging following LDR prostate brachytherapy. Radiother Oncol 86 (2008) 288
27. Schiff J.D., Bar-Chama N., Cesaretti J., et al. Early use of a phosphodiesterase inhibitor after brachytherapy restores and preserves erectile function. BJU Int 98 (2006) 1255-1258
28. Fossa S.D., Woehre H., Kurth K.H., et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol 31 Suppl. 3 (1997) 3-8
29. Frank S.J., Pisters L.L., Davis J., et al. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177 (2007) 2151-2156 [discussion 2156]
30. Merrick G.S., Wallner K.E., and Butler W.M. Management of sexual dysfunction after prostate brachytherapy. Oncology (Williston Park) 17 (2003) 52-62 [discussion 62, 67-70, 73, 2003]
31. Potters L., Torre T., Fearn P.A., et al. Potency after permanent prostate brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1235-1242
32. Burnett A.L., Aus G., Canby-Hagino E.D., et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol (2007)
33. Merrick G.S., and Butler W.M. The dosimetry of brachytherapy-induced erectile dysfunction. Med Dosim 28 (2003) 271-274
34. Rosen R.C., Riley A., Wagner G., et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49 (1997) 822-830
35. Rosas S.E., Joffe M., Franklin E., et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 59 (2001) 2259-2266
36. Merrick G.S., Butler W.M., Lief J.H., et al. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology 53 (1999) 1112-1116
37. Merrick G.S., Butler W.M., Dorsey A.T., et al. Seed fixity in the prostate/periprostatic region following brachytherapy. Int J Radiat Oncol Biol Phys 46 (2000) 215-220
38. Reed D.R., Wallner K.E., Merrick G.S., et al. A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy. Brachytherapy 6 (2007) 129-134
39. Tapen E.M., Blasko J.C., Grimm P.D., et al. Reduction of radioactive seed embolization to the lung following prostate brachytherapy. Int J Radiat Oncol Biol Phys 42 (1998) 1063-1067
40. Bloch B.N., Lenkinski R.E., Helbich T.H., et al. Prostate postbrachytherapy seed distribution: comparison of high-resolution, contrast-enhanced, T1- and T2-weighted endorectal magnetic resonance imaging versus computed tomography: initial experience. Int J Radiat Oncol Biol Phys (2007)
41. Salembier C., Lavagnini P., Nickers P., et al. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol 83 (2007) 3-10
42. Wilder R.B., Chou R.H., Ryu J.K., et al. Potency preservation after three-dimensional conformal radiotherapy for prostate cancer: preliminary results. Am J Clin Oncol 23 (2000) 330-333
43. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Radiation therapy as treatment for stage T1c prostate cancers. World J Urol 15 (1997) 369-372
44. Rosen R.C., Wing R., Schneider S., et al. Epidemiology of erectile dysfunction: the role of medical comorbidities and lifestyle factors. Urol Clin North Am 32 (2005) 403-417